These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9537026)

  • 1. Immunization with the light chain and the VL domain of the isologous myeloma protein 315 inhibits growth of mouse plasmacytoma MOPC315.
    Jørgensen T; Gaudernack G; Hannestad K
    Scand J Immunol; 1980; 11(1):29-35. PubMed ID: 9537026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T helper lymphocytes recognize the VL domain of the isologous mouse myeloma protein 315.
    Jørgensen T; Hannestad K
    Scand J Immunol; 1979; 10(4):317-23. PubMed ID: 93775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small hypervariable segment in the variable domain of an immunoglobulin light chain stimulates formation of anti-idiotypic suppressor T cells.
    Sakato N; Semma M; Eisen HN; Azuma T
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5396-400. PubMed ID: 6215651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutations in the variable region of the lambda 2 chain of M315 suppression of antibodies to the idiotype of M315.
    Sakato N; Azuma T; Fujio H
    Biken J; 1985 Dec; 28(3-4):51-8. PubMed ID: 2423068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-induced redistribution and augmentation of surface-bound myeloma protein on MOPC 315 plasmacytoma cells.
    Hannestad K; Gaudernack G
    Scand J Immunol; 1977; 6(1-2):59-76. PubMed ID: 403594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infrequent utilization of the immunoglobulin heavy chain variable region(s) identical or closely related to that of MOPC315 myeloma protein in the functional V region formation in B-precursor cell lines.
    Sugiyama H; Minami Y; Komori T; Sakato N; Kishimoto S
    Immunology; 1989 Dec; 68(4):453-7. PubMed ID: 2514136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural abundance of lambda2-light chains in inbred mice.
    Cotner T; Eisen HN
    J Exp Med; 1978 Nov; 148(5):1388-99. PubMed ID: 102727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of antibody and helper T-cell responses to the isologous myeloma protein W3129 and its subunits.
    Bogen B; Hannestad K
    Mol Immunol; 1984 Jul; 21(7):653-61. PubMed ID: 6205254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of idiotopes on MOPC 315 IgA using monoclonal antiidiotypic antibodies.
    Nusair T; Baumal R; Rosenstein R; Jørgensen T; Marks A
    Mol Immunol; 1983 May; 20(5):537-47. PubMed ID: 6192325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T helper cells recognize an idiotope located on peptide 88-114/117 of the light chain variable domain of an isologous myeloma protein (315).
    Jørgensen T; Bogen B; Hannestad K
    J Exp Med; 1983 Dec; 158(6):2183-8. PubMed ID: 6227679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of lambda 1 and lambda 2 murine light chains by carrier-specific isologous T helper cells; effect of L-H chain assembly.
    Bogen B; Jørgensen T; Hannestad K
    Eur J Immunol; 1983 May; 13(5):353-9. PubMed ID: 6189725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of BALB/c anti-idiotypic antibodies against the BALB/c myeloma protein 315 does not require an intact ligand-binding site.
    Jorgensen T; Gaudernack G; Hannestad K
    Scand J Immunol; 1977; 6(4):311-8. PubMed ID: 67635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The idiotypic network: the murine MOPC315 anti-DNP system.
    Amor M; Mariamé B; Voegtlé D; Cazenave PA
    Ann Immunol (Paris); 1982; 133D(3):255-62. PubMed ID: 6984635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine specificity analysis of idiotype-specific suppressor factors that block a delayed-type hypersensitivity response to M315: evidence supporting a role for somatic mutations in the variable region of the lambda 2 chain of M315.
    Sakato N; Azuma T; Fujio H
    Immunology; 1986 Nov; 59(3):365-72. PubMed ID: 2431996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T helper cell recognition of idiotopes on lambda 2 light chains of M315 and T952: evidence for dependence on somatic mutations in the third hypervariable region.
    Bogen B; Jørgensen T; Hannestad K
    Eur J Immunol; 1985 Mar; 15(3):278-81. PubMed ID: 2579823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two M315 idiotopes defined by isologous monoclonal antibodies: one depends on germline and the other on mutated murine lambda 2 light chain sequences.
    Kristoffersen G; Hannestad K; Hansen T
    Scand J Immunol; 1987 Nov; 26(5):535-46. PubMed ID: 3120305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H--2-linked genes control immune response to V-domains of myeloma protein 315.
    Jørgensen T; Hannestad K
    Nature; 1980 Nov; 288(5789):396-7. PubMed ID: 6776419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses to an adjuvant-free native syngeneic myeloma protein (M315).
    Kristoffersen G; Hannestad K
    Eur J Immunol; 1988 Nov; 18(11):1785-90. PubMed ID: 2974426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assay for the quantitative inhibition of anti-immunoglobulin antibodies performed at the cell surface. Studies with anti-kappa and anti-mu chain antibodies.
    Stanislawski M; Mitard M; Harel A
    Mol Immunol; 1979 May; 16(5):317-26. PubMed ID: 114751
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel immunization protocol and ELISA screening methods used to obtain and characterize monoclonal antibodies specific for human light chain variable-region subgroups.
    Abe M; Goto T; Wolfenbarger D; Weiss DT; Solomon A
    Hybridoma; 1993 Aug; 12(4):475-83. PubMed ID: 8244419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.